These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 21094987)

  • 21. A role for the C2 domain of factor VIII in binding to von Willebrand factor.
    Saenko EL; Shima M; Rajalakshmi KJ; Scandella D
    J Biol Chem; 1994 Apr; 269(15):11601-5. PubMed ID: 7512568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
    Hubbard AR; Rigsby P; Barrowcliffe TW
    Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction.
    Mazurier C; Dieval J; Jorieux S; Delobel J; Goudemand M
    Blood; 1990 Jan; 75(1):20-6. PubMed ID: 2104761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-affinity von Willebrand factor binding does not affect the anatomical or hepatocellular distribution of factor VIII in rats.
    Øie CI; Roepstorff K; Behrens C; Bøggild Kristensen J; Karpf DM; Bolt G; Gudme CN; Kjalke M; Smedsrød B; Appa RS
    J Thromb Haemost; 2016 Sep; 14(9):1803-13. PubMed ID: 27378673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind factor VIII and affects its multimerization.
    Jorieux S; Gaucher C; Goudemand J; Mazurier C
    Blood; 1998 Dec; 92(12):4663-70. PubMed ID: 9845532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The fraction of recombinant factor VIII:Ag unable to bind von Willebrand factor has no FVIII coagulant activity: studies in vitro.
    Ofosu FA; Tse H; Naqvi A; Bhakta H; Song Y
    Haemophilia; 2012 Nov; 18(6):917-25. PubMed ID: 22672786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New variant of von Willebrand disease with defective binding to factor VIII.
    Nishino M; Girma JP; Rothschild C; Fressinaud E; Meyer D
    Blood; 1989 Oct; 74(5):1591-9. PubMed ID: 2506947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor VIII inhibitor antibodies with C2 domain specificity are less inhibitory to factor VIII complexed with von Willebrand factor.
    Suzuki T; Arai M; Amano K; Kagawa K; Fukutake K
    Thromb Haemost; 1996 Nov; 76(5):749-54. PubMed ID: 8950785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor protein.
    He S; Cao H; Magnusson CG; Eriksson-Berg M; Mehrkash M; Schenck-Gustafsson K; Blombäck M
    Thromb Res; 2001 Aug; 103(3):241-8. PubMed ID: 11672586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII.
    Fischer BE; Kramer G; Mitterer A; Grillberger L; Reiter M; Mundt W; Dorner F; Eibl J
    Thromb Res; 1996 Oct; 84(1):55-66. PubMed ID: 8885147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A monoclonal antibody (NMC-VIII/10) to factor VIII light chain recognizing Glu1675-Glu1684 inhibits factor VIII binding to endogenous von Willebrand factor in human umbilical vein endothelial cells.
    Shima M; Yoshioka A; Nakajima M; Nakai H; Fukui H
    Br J Haematol; 1992 Aug; 81(4):533-8. PubMed ID: 1390241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of surface plasmon resonance for studies of protein-protein and protein-phospholipid membrane interactions. Application to the binding of factor VIII to von Willebrand factor and to phosphatidylserine-containing membranes.
    Saenko E; Sarafanov A; Greco N; Shima M; Loster K; Schwinn H; Josic D
    J Chromatogr A; 1999 Aug; 852(1):59-71. PubMed ID: 10480230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of von Willebrand factor in platelets of patients with various forms of von Willebrand disease: is there a clinical relevance?
    Kertzscher F; Müller AE; Lenk H
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S177-9. PubMed ID: 10650864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibody to factor VIII that has less reactivity to factor VIII/von Willebrand factor complex.
    Amano K; Arai M; Koshihara K; Suzuki T; Kagawa K; Nishida Y; Fukutake K
    Am J Hematol; 1995 Aug; 49(4):310-7. PubMed ID: 7639276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use.
    Murdock PJ; Woodhams BJ; Matthews KB; Pasi KJ; Goodall AH
    Thromb Haemost; 1997 Oct; 78(4):1272-7. PubMed ID: 9364997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological Roles of the von Willebrand Factor-Factor VIII Interaction.
    Kiouptsi K; Reinhardt C
    Subcell Biochem; 2020; 94():437-464. PubMed ID: 32189311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor.
    Vlot AJ; Koppelman SJ; van den Berg MH; Bouma BN; Sixma JJ
    Blood; 1995 Jun; 85(11):3150-7. PubMed ID: 7756647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.